A Randomized Double Blind Placebo Controlled Parallel Group Study Of The Efficacy And Safety Of Concomitant Administration Of Celecoxib And Pregabalin Compared With Celecoxib Monotherapy, In Patients With Chronic Low Back Pain Having A Neuropathic Component

Trial Profile

A Randomized Double Blind Placebo Controlled Parallel Group Study Of The Efficacy And Safety Of Concomitant Administration Of Celecoxib And Pregabalin Compared With Celecoxib Monotherapy, In Patients With Chronic Low Back Pain Having A Neuropathic Component

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 03 Sep 2016

At a glance

  • Drugs Pregabalin (Primary) ; Celecoxib
  • Indications Back pain; Neuropathic pain
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 21 May 2015 Status changed from active, no longer recruiting to discontinued, as reported by ClinicalTrials.gov.
    • 19 May 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.
    • 12 Dec 2014 Planned End Date changed from 1 Oct 2015 to 1 Dec 2015, according to the ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top